NEW YORK STOCK EXCHANGE, INC. · DNA
-1.07% · -$0.1000 · Vol 646.6K
Live · updated 15:19:26 ET
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc

Life Sciences Tools & Services
$9.27
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
DNA
Ginkgo Bioworks Holdings Inc
Tue Aug 4 · last completed session · daily score · 21h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

53/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 6/6 factors with data · Tue Aug 4 · last completed session · daily score · 21h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is DNA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading DNA catalysts
About Ginkgo Bioworks Holdings Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
485
Country
US

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.29
Day high
$9.65
Day low
$9.23
Previous close
$9.37
52W high
$16.14
-42.57% from high
52W low
$5.48
36% of range
Market cap
$612.1M
EPS
$-5.6400
Beta
2.47
Shares out
65.3M
Volume
646.6K
0.62× rel vol
Avg volume
1M
VWAP
$9.40
Price history computed in-house
1W
+21.65%
1M
-8.31%
3M
-10.17%
1Y
-35.08%
YTD
+11.55%
SMA 50 $8.76 · above
SMA 200 $8.79 · above
52W position 36%

DNA overview

Loading financial statements
Loading DNA Form 4 filings
Public disclosures

Congress activity in DNA

No receipt-qualified Congressional disclosure is present for DNA in the cached public ledger.

Federal contracts

DNA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DNA in this window.
Lobbying spend

DNA lobbying filings, year to date.

Registered lobbying filings matched to Ginkgo Bioworks Holdings Inc.

$300.0K
Refresh interval: 12hSource: LDA disclosure filings
Budget/Appropriations Defense Medical/Disease Research/Clinical LabsMedical/Disease Research/Clinical Labs
Filing
$60.0K
GINKGO BIOWORKS INC.

CROSSROADS STRATEGIES, LLC

Jul 18, 2026
Filing
$60.0K
GINKGO BIOWORKS INC.

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Jul 10, 2026
Filing
$60.0K
GINKGO BIOWORKS INC.

CROSSROADS STRATEGIES, LLC

Apr 20, 2026
Loading news for DNA
Analyst ratings
Sovereign unlock shows live analyst consensus for DNA.
Options
Sovereign unlock shows live options positioning for DNA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.